Anti-Asthmatics And Copd Drugs Market - By Type Of Therapy (Preventive, Curative), By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By End-Users (Asthma Patients, Copd Patients), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $ 4000.00 $3200.00 | Pages : 309 | Published : April 2020 | SKU CODE : o&s130 | Format :

Request Sample

Anti-Asthmatics And COPD Drugs Market Definition

The anti-asthmatics and COPD drugs market consists of sales of anti-asthmatics and COPD drugs by entities (organizations, sole traders and partnerships) that manufacture anti-asthmatics and COPD drugs which are used to prevent and treat asthma and chronic obstructive pulmonary disease (COPD). The anti-asthmatics and COPD drug industry includes establishments that manufacture anti-asthmatics and COPD drugs such as bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.

Anti-Asthmatics And COPD Drugs Market Size

The global anti-asthmatics and COPD drugs market reached a value of nearly $40,162.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 4.4% since 2015, and is expected to grow at a CAGR of 4.1% to nearly $47,176.2 million by 2023.Also the market is expected to growth to $51,164.1 million in 2025 at a CAGR of 4.1% and to $63,579.9 million in 2030 at a CAGR of 4.4%.

Growth in the historic period resulted from increased prevalence of respiratory diseases, increasing incidence of tobacco smoking, global warming, geriatric population, new methods for drug discovery, and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents, and political uncertainties.

Going forward, increased popularity of e-cigarettes/vaping, rising obesity levels, technology, large pool of undiagnosed population, use of anti-asthmatics and COPD drugs to treat covid-19 patients, and increasing consumption of fats are expected to drive the market. Factors that could hinder the growth of the anti-asthmatics and COPD drugs market in the future include side effects associated with respiratory drugs, reduction in free trade, and stringent regulations.

Anti-Asthmatics And COPD Drugs Market Drivers

The key driver of the anti-asthmatics and COPD drugs market include:

Increased Incidence Of Tobacco Smoking – The increased use of tobacco led to a rise in tobacco related respiratory diseases such as COPD which in turn drove the anti-asthmatic and COPD drugs market during the historic period. While the global rate of smoking reduced, the increase in the population led to an increased number of smokers. The tobacco epidemic is a major public health issue globally and as of 2019, the annual number of deaths that could be attributed to tobacco related diseases was more than 8 million. In the UK, as of 2018, around 14.7% of population aged 18 years and above smoked cigarettes. Smoking continued to be popular in many regions, especially in Asia, Africa and the Middle East. Around 80% of the world`s 1.1 billion smokers lived in low- and middle-income countries. This trend increased the prevalence of chronic respiratory diseases, driving the market for anti-asthmatics and respiratory diseases.

Anti-Asthmatics And COPD Drugs Market Restraints

The key restraint on the anti-asthmatics and COPD drugs market include:

Stringent regulations – Stringent regulations such as approvals of asthma and COPD drugs have always been a major challenge in the anti-asthmatics and COPD drugs market. For instance, in 2018, in the U.S, the US FDA disapproved GlaxoSmithKline`s use of mepolizumab in the care of patients with chronic obstructive pulmonary disease (COPD) on the grounds that more clinical data is required. The FDA said it needed more clinical evidences to support the approval of the drug. These factors are expected to limit the growth of the anti-asthmatics and COPD drugs market.

Anti-Asthmatics And COPD Drugs Market Trends

Major trends influencing the anti-asthmatics and COPD drugs market include:

Collaborations In The Anti-Asthmatics and COPD Drugs Market

Many companies in the anti-asthmatics and COPD drugs market are strategically partnering and collaborating with other companies to broaden their product portfolios. These collaborations are helping drug manufacturing companies to enhance their product strength in specific therapy areas. For instance, in March 2017, AstraZeneca announced collaboration with Circassia Pharmaceuticals Plc; a UK based respiratory biopharmaceutical company, for the development and commercialization of Tudorza and Duaklir in the US. Tudorza and Duaklir are used in the treatment of COPD. Similarly, in August 2018, Haplogen, Austria based biotechnology company, announced collaboration with German firm Bayer, to develop drugs for chronic obstructive pulmonary disease (COPD) and other pulmonary diseases.

New Biologic Therapy Medicines To Treat Severe Asthma

Biologic therapy medicines are increasingly being used in the treatment of severe asthma. A biologic is a medication made from the cells of living organisms, such as bacteria, and modified to target specific molecules in humans. They target specific antibodies and molecules in the body that contribute to asthma, and disrupt the pathways that lead to inflammation. Biologics are used for treating patients who continue to have symptoms such as coughing, shortness of breath, and wheezing, despite use of standard daily controller medications. For example, drugs that are used as biologic therapy medicines are Xolair (omalizumab), Nucala(mepolizumab), Cinqair(reslizumab), Fasenra(benralizumab), and Dupixent(dupilumab).

Opportunities And Recommendations In The Anti-Asthmatics And COPD Drugs Market

Opportunities – The top growth potential in the anti-asthmatics and COPD drugs market by drug class will arise in combination drugs market, which will gain $2,789.8 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by end user will arise in the asthma patients market, which will gain $4,060.0 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by distribution channel will arise in general pharmacies market, which will gain $3,593.2 million of global annual sales by 2023. The anti-asthmatics and COPD drugs market size will gain the most in the USA at $2,283.6 million.

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the anti-asthmatics and COPD drugs companies to focus on personalized medicines, focus on increasing the production temporarily during the COVID-19 pandemic, leverage e-commerce to maximize reach and revenues, provide competitively priced offerings in low-income countries to reach new users, and focus on increasing awareness on asthma and COPD.

Anti-Asthmatics And COPD Drugs Market Segmentation

The anti-asthmatics and COPD drugs market is segmented by type of drug class, by end-user, by distribution channel, by therapy, by patients’ age group, by prescription, by drug type and by geography.
By Type Of Drug Class - The anti-asthmatics and COPD drugs market can be segmented by type of drug class into
    • a) Combination Drugs
    • b) Bronchodilators
    • c) Monoclonal Antibodies
    • d) Anti-Inflammatory Drugs
The combination drugs market was the largest segment of the anti-asthmatics and COPD drugs market by drug class, accounting for $14,964.9 million or 37.3% of the total market in 2019. The monoclonal antibodies market is expected to be the fastest-growing segment going forward at a CAGR of 7.4%.
By End-Users – The anti-asthmatics and COPD drugs market is segmented by end-user into
    • a) Asthma Patients
    • b) COPD Patients
The asthma patients was the largest segment of the anti-asthmatics and COPD drugs market by end user, accounting for $24,791.3 million or 61.7% of the total market in 2019. The COPD patients market is expected to be the fastest-growing segment going forward at a CAGR of 4.5%.
By Distribution Channel - The anti-asthmatics and COPD drugs market can be segmented by distribution channel into
    • a) General Pharmacies
    • b) Hospital Pharmacies
    • c) Online Retailers
The general pharmacies was the largest segment of the anti-asthmatics and COPD drugs market by distribution channel, accounting for $26,424.3 million or 65.8% of the total market in 2019. The online retailers market is expected to be the fastest-growing segment going forward at a CAGR of 9.6%.
By Type Of Therapy - The anti-asthmatics and COPD drugs market can be segmented by type of therapy into
    • a) Preventive
    • b) Curative
The preventive was the largest segment of the anti-asthmatics and COPD drugs market by therapy, accounting for $21,791.0 million or 54.3% of the total market in 2019.
By Route Of Administration - The anti-asthmatics and COPD drugs market can be segmented by route of administration into
    • a) Inhaled
    • b) Intravenous and Subcutaneous
    • c) Oral
The inhaled was the largest segment of the anti-asthmatics and COPD drugs market by route of administration, accounting for $29,360.8 million or 73.1% of the total market in 2019.
By Patients’ Age Group - The anti-asthmatics and COPD drugs market can be segmented by patients’ age group into
    • a) Below 5 Years
    • b) 5 to 14 Years
    • c) 15-69 Years
    • d) 70+ Years
The 15-69 years age group was the largest segment of the anti-asthmatics and COPD drugs market by age group, accounting for $20,220.7 million or 50.3% of the total market in 2019.
By Type Of Prescription - The anti-asthmatics and COPD drugs market can be segmented by type of prescription into
    • a) Prescription
    • b) OTC
The prescription drugs was the largest segment of the anti-asthmatics and COPD drugs market by prescription, accounting for $37,521.9 million or 93.4% of the total market in 2019.
By Type Of Drug - The anti-asthmatics and COPD drugs market can be segmented by type of drug into
    • a) Branded
    • b) Generics
The branded drugs was the largest segment of the anti-asthmatics and COPD drugs market by drug type, accounting for $38,378.9 million or 95.6% of the total market in 2019.
By Geography- The anti-asthmatics and COPD drugs market is segmented by geography into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • Indonesia
      • South Korea
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America was the largest region in the anti-asthmatics and COPD drugs market, accounting for 47.7% of the global market in 2019. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the anti-asthmatics and COPD drugs market will be Asia-Pacific and the Middle East.

Anti-Asthmatics And COPD Drugs Competitive Landscape

Major Competitors are:
    • • GlaxoSmithKline plc
    • • AstraZeneca plc
    • • Boehringer Ingelheim GmbH
    • • F. Hoffmann-La Roche Ltd.
    • • Novartis AG
Other Competitors Include:
    • • Sanofi S.A.
    • • Chiesi Farmaceutici S.p.A.
    • • Merck & Co., Inc.
    • • Teva Pharmaceutical Industries Limited
    • • Sumitomo Dainippon Pharma Co., Ltd.
    • • China National Pharmaceutical Group Co., Ltd. (Sinopharm)
    • • Shanghai Acebright Pharmaceuticals Group Co., Ltd.
    • • Jiangsu Hengrui Medicine Co., Ltd.
    • • Hanmi Pharmaceutical
    • • Cipla Limited
    • • Aurobindo Pharma Limited
    • • KYORIN Holdings, Inc.
    • • Nichi-Iko Pharmaceutical Co., Ltd.
    • • Otsuka Pharmaceutical Co., Ltd.
    • • Daewoong Pharmaceutical Co., Ltd.
    • • Shanghai Anovent Pharma
    • • China Meheco Group Co., Ltd
    • • Lupin Limited
    • • ASGEN Pharmaceutical Co., Ltd.
    • • Abbott Laboratories
    • • Vectura Group
    • • Pfizer
    • • Mylan
    • • Bristol Myers Squibb
    • • Apotex Inc.
    • • EMS Pharma
    • • Hypermarcas
    • • Ache
    • • Eurofarma
    • • Bayer
    • • Biolab Farmaceuticad
    • • Cristalia
    • • Libbs
    • • Julphar
    • • Neopharma
    • • Adcock Ingram
    • • Cipla Medpro South Africa (Pty) Limited
    • • Aspen Nigeria

  1. 1. Anti-Asthmatics And COPD Drugs Market Executive Summary
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Drug Class
    • 6.1.3. Segmentation By End User
    • 6.1.4. Segmentation By Distribution Channel
    • 6.1.5. Segmentation By Therapy
    • 6.1.6. Segmentation By Route Of Administration
    • 6.1.7. Segmentation By Age Group
    • 6.1.8. Segmentation By Prescription
    • 6.1.9. Segmentation By Drug Type
  7. 7. Anti-Asthmatics And COPD Drugs Market Characteristics
    • 7.1. Market Segmentation By Class
      • 7.1.1. Bronchodilators
      • 7.1.2. Anti-Inflammatory Drugs
      • 7.1.3. Monoclonal Antibodies
      • 7.1.4. Combination Drugs
    • 7.2. Market Segmentation By End User
      • 7.2.1. Asthma Patients
      • 7.2.2. COPD Patients
    • 7.3. Market Segmentation By Distribution Channel
      • 7.3.1. Hospital Pharmacies
      • 7.3.2. General Pharmacies
      • 7.3.3. Online Retailers
    • 7.4. Market Segmentation By Therapy
      • 7.4.1. Preventive
      • 7.4.2. Curative
    • 7.5. Market Segmentation By Route Of Administration
      • 7.5.1. Oral
      • 7.5.2. Inhaled
      • 7.5.3. Intravenous
      • 7.5.4. Subcutaneous
    • 7.6. Market Segmentation By Age Group
      • 7.6.1. Below 5
      • 7.6.2. 5-14
      • 7.6.3. 15-60
      • 7.6.4. Above 60
    • 7.7. Market Segmentation By Prescription
      • 7.7.1. Prescription
      • 7.7.2. Over The Counter (OTC)
    • 7.8. Market Segmentation By Drug Type
      • 7.8.1. Branded
      • 7.8.2. Generic
  8. 8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis
    • 8.1.1. Raw Material And Equipment Procurement
    • 8.1.2. Manufacturing, Processing and Packaging
    • 8.1.3. Distribution
    • 8.1.4. Physicians
    • 8.1.5. End users
  9. 9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  10. 10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales
    • 10.1.1. Ellipta
    • 10.1.2. Spiriva
    • 10.1.3. Symbicort
    • 10.1.4. Advair
    • 10.1.5. Pulmicort
    • 10.1.6. Ventolin
    • 10.1.7. Xolair
    • 10.1.8. Nucala
    • 10.1.9. Flovent
    • 10.1.10. Fasenra
  11. 11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs
    • 11.1.1. Background
    • 11.1.2. Innovators
  12. 12. Anti-Asthmatics And COPD Drugs Market, Customer Information
    • 12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese
    • 12.2. Britons Experience Inadequate Treatment Of COPD
    • 12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers
    • 12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits
    • 12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues
  13. 13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market
    • 13.1. Consumer Perception
    • 13.2. High Mortality Among Asthma Patients
    • 13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment
  14. 14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
    • 14.1.1. India
    • 14.1.2. China
    • 14.1.3. Japan
    • 14.1.4. Australia
    • 14.1.5. South Korea
    • 14.1.6. Indonesia
    • 14.1.7. USA
    • 14.1.8. Canada
    • 14.1.9. Mexico
    • 14.1.10. UK
    • 14.1.11. Germany
    • 14.1.12. France
    • 14.1.13. Russia
    • 14.1.14. Brazil
  15. 15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
    • 15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market
    • 15.2. Increasing Demand For Personalized Medicines
    • 15.3. Demand For Aerosol Respiratory Drugs
    • 15.4. Use Of Biomarker For Precision Medicine
    • 15.5. Rise Of Generic Respiratory Drugs
    • 15.6. Combination Drug Therapy To Treat COPD
    • 15.7.New Biologic Therapy Medicines To Treat Severe Asthma
  16. 16. Asthma And COPD Prevalence Overview
    • 16.1. Asthma
    • 16.2. COPD
  17. 17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth
    • 17.1. Market Size
    • 17.2. Historic Market Growth, 2015 – 2019, Value ($ Million)
      • 17.2.1. Historic Drivers Of The Market 2015-2019
      • 17.2.2. Historic Restraints Of The Market 2015-2019
    • 17.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
      • 17.3.1. Forecast Drivers Of The Market 2019-2023
      • 17.3.2. Forecast Restraints Of The Market 2019-2023
  18. 18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis
    • 18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  19. 19. Global Anti-Asthmatics And COPD Drugs Market Segmentation
    • 19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.1.1. Combination Drugs
      • 19.1.2. Bronchodilators
      • 19.1.3. Monoclonal Antibodies
      • 19.1.4. Anti-Inflammatory Drugs
    • 19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.2.1. Asthma Patients
      • 19.2.2. COPD Patients
    • 19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
      • 19.3.1. General Pharmacies
      • 19.3.2. Hospital Pharmacies
      • 19.3.3. Online Retailers
    • 19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value ($ Million)
      • 19.4.1. Preventive
      • 19.4.2. Curative
    • 19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value ($ Million)
      • 19.5.1. Inhaled
      • 19.5.2. Intravenous and Subcutaneous
      • 19.5.3. Oral
    • 19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019, Value ($ Million)
      • 19.6.1. 15-69 Years
      • 19.6.2. 70+ Years
      • 19.6.3. Below 5 Years
    • 19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value ($ Million)
      • 19.7.1. Prescription
      • 19.7.2. OTC
    • 19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value ($ Million)
      • 19.8.1. Branded
      • 19.8.2. Generics
  20. 20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
    • 20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
      • 20.1.1. Region Information
      • 20.1.2. Market Information
      • 20.1.3. Background Information
      • 20.1.4. Government Initiatives
      • 20.1.5. New Drug Trials And Approvals
      • 20.1.6. Major Associations
      • 20.1.7. Taxes Levied
      • 20.1.8. Investments
      • 20.1.9. Major Companies
    • 20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 20.7. China Anti-Asthmatics And COPD Drugs Market
    • 20.8. China Anti-Asthmatics And COPD Drugs Market Overview
      • 20.8.1. Country Information
      • 20.8.2. Market Information
      • 20.8.3. Background Information
      • 20.8.4. Government Initiatives
      • 20.8.5. New Drug Trials And Approvals
      • 20.8.6. Major Associations
      • 20.8.7. Taxes Levied
      • 20.8.8. Investments
      • 20.8.9. Major Companies
    • 20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.13. India Anti-Asthmatics And COPD Drugs Market
    • 20.14. India Anti-Asthmatics And COPD Drugs Market Overview
      • 20.14.1. Country Information
      • 20.14.2. Market Information
      • 20.14.3. Background Information
      • 20.14.4. Government Initiatives
      • 20.14.5. Major Associations
      • 20.14.6. Taxes Levied
      • 20.14.7. Investments
      • 20.14.8. Major Companies
    • 20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.19. Japan Anti-Asthmatics And COPD Drugs Market
    • 20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview
      • 20.20.1. Country Information
      • 20.20.2. Market Information
      • 20.20.3. Background Information
      • 20.20.4. Government Initiatives
      • 20.20.5. New Drug Trials And Approvals
      • 20.20.6. Major Associations
      • 20.20.7. Taxes Levied
      • 20.20.8. Investments
      • 20.20.9. Major Companies
    • 20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.25. Australia Anti-Asthmatics And COPD Drugs Market
    • 20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.30. Indonesia Anti-Asthmatics And COPD Drugs Market
    • 20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.35. South Korea Anti-Asthmatics And COPD Drugs Market
    • 20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  21. 21. Western Europe Anti-Asthmatics And COPD Drugs Market
    • 21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
      • 21.1.1. Region Information
      • 21.1.2. Market Information
      • 21.1.3. Background Information
      • 21.1.4. Government Initiatives
      • 21.1.5. New Drug Trials And Approvals
      • 21.1.6. Major Associations
      • 21.1.7. Taxes Levied
      • 21.1.8. Major Companies
    • 21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 21.7. UK Anti-Asthmatics And COPD Drugs Market
    • 21.8. UK Anti-Asthmatics And COPD Drugs Market Overview
      • 21.8.1. Country Information
      • 21.8.2. Market Information
      • 21.8.3. Background Information
      • 21.8.4. Government Initiatives
      • 21.8.5. New Drug Trials And Approvals
      • 21.8.6. Major Associations
      • 21.8.7. Taxes Levied
      • 21.8.8. Major Companies
    • 21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.13. Germany Anti-Asthmatics And COPD Drugs Market
    • 21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.18. France Anti-Asthmatics And COPD Drugs Market
    • 21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  22. 22. Eastern Europe Anti-Asthmatics And COPD Drugs Market
    • 22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
      • 22.1.1. Region Information
      • 22.1.2. Market Information
      • 22.1.3. Background Information
      • 22.1.4. New Drug Trials And Approvals
      • 22.1.5. Major Associations
      • 22.1.6. Taxes Levied
      • 22.1.7. Major Companies
    • 22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.6. Russia Anti-Asthmatics And COPD Drugs Market
    • 22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  23. 23. North America Anti-Asthmatics And COPD Drugs Market
    • 23.1. North America Anti-Asthmatics And COPD Drugs Market Overview
      • 23.1.1. Region Information
      • 23.1.2. Market Information
      • 23.1.3. Background Information
      • 23.1.4. Government Initiatives
      • 23.1.5. New Drug Trials And Approvals
      • 23.1.6. Major Associations
      • 23.1.7. Taxes Levied
      • 23.1.8. Investments
      • 23.1.9. Major Companies
    • 23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 23.7. USA Anti-Asthmatics And COPD Drugs Market
    • 23.8. USA Anti-Asthmatics And COPD Drugs Market Overview
      • 23.8.1. Country Information
      • 23.8.2. Market Information
      • 23.8.3. Background Information
      • 23.8.4. Government Initiatives
      • 23.8.5. Major Associations
      • 23.8.6. Taxes Levied
      • 23.8.7. Investments
      • 23.8.8. Major Companies
    • 23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  24. 24. South America Anti-Asthmatics And COPD Drugs Market
    • 24.1. South America Anti-Asthmatics And COPD Drugs Market Overview
      • 24.1.1. Region Information
      • 24.1.2. Market Information
      • 24.1.3. Background Information
      • 24.1.4. Major Associations
      • 24.1.5. Government Initiatives
      • 24.1.6. Investments
      • 24.1.7. Major Companies
    • 24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis
    • 24.7. Brazil Anti-Asthmatics And COPD Drugs Market
    • 24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  25. 25. Middle East Anti-Asthmatics And COPD Drugs Market
    • 25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
      • 25.1.1. Region Information
      • 25.1.2. Market Information
      • 25.1.3. Background Information
      • 25.1.4. Government Initiatives
      • 25.1.5. Major Associations
      • 25.1.6. Taxes Levied
      • 25.1.7. Major Companies
    • 25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  26. 26. Africa Anti-Asthmatics And COPD Drugs Market
    • 26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
      • 26.1.1. Region Information
      • 26.1.2. Market Information
      • 26.1.3. Background Information
      • 26.1.4. Government Initiatives
      • 26.1.5. Major Associations
      • 26.1.6. Taxes Levied
      • 26.1.7. Investments
      • 26.1.8. Major Companies
    • 26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
    • 26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
    • 26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
  27. 27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape
    • 27.1. Company Profiles
    • 27.2. GlaxoSmithKline plc.
      • 27.2.1. Company Overview
      • 27.2.2. Products And Services
      • 27.2.3. Business Strategy
      • 27.2.4. Financial Overview
    • 27.3. AstraZeneca plc.
      • 27.3.1. Company Overview
      • 27.3.2. Products And Services
      • 27.3.3. Business Strategy
      • 27.3.4. Financial Overview
    • 27.4. Boehringer-Ingelheim GmbH
      • 27.4.1. Company Overview
      • 27.4.2. Products And Services
      • 27.4.3. Business Strategy
      • 27.4.4. Financial Overview
    • 27.5. F. Hoffmann-La Roche Ltd
      • 27.5.1. Company Overview
      • 27.5.2. Products And Services
      • 27.5.3. Business Strategy
      • 27.5.4. Financial Overview
    • 27.6. Novartis AG
      • 27.6.1. Company Overview
      • 27.6.2. Products And Services
      • 27.6.3. Business Strategy
      • 27.6.4. Financial Overview
  28. 28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
    • 28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical
    • 28.2. ResMed Acquired Propeller Health
    • 28.3. Circassia Acquired AstraZeneca’s COPD Treatment Tudorza
    • 28.4. RecipharmAB Acquired Sanofi’s Inhalation Contract Manufacturing Business
    • 28.5. Mast Therapeutics, Inc. Merged With Savara Inc.
    • 28.6. Mylan N.V. Acquired Majority Stake In Meda AB
    • 28.7. Vectura Group Merged With Skyepharma
    • 28.8. Recordati Acquired Italchimici S.p.A.
    • 28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc.
  29. 29. Market Background: Respiratory Diseases Drugs Market
    • 29.1. Respiratory Diseases Drugs Market Characteristics
      • 29.1.1. Market Definition
      • 29.1.2. Segmentation By Type
      • 29.1.3. Anti-Asthmatics And COPD Drugs
      • 29.1.4. Cough And Cold Preparations
    • 29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, Value ($ Billion)
    • 29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
    • 29.4. Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast, By Region
  30. 30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies
    • 30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Countries Offering Most New Opportunities
    • 30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities
    • 30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Growth Strategies
      • 30.3.1. Market Trend Based Strategies
      • 30.3.2. Competitor Strategies
  31. 31. Global Anti-Asthmatics And COPD Drugs Market Recommendations
    • 31.1. Conclusions
    • 31.2. Recommendations
      • 31.2.1. Product
      • 31.2.2. Place
      • 31.2.3. Price
      • 31.2.4. Promotion
  32. 32. Appendix
    • 32.1. Market Data Sources
    • 32.2. Research Methodology
    • 32.3. Currencies
    • 32.4. Research Inquiries
    • 32.5. The Business Research Company
    • 32.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  • Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019
  • Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019
  • Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
  • Table 5: Prevalence Of Asthma, 2014-2017
  • Table 6: Prevalence Of COPD, 2014-2017
  • Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Table 24: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 25:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 26: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 27: Air Pollution And Air Quality Index, Asia-Pacific Countries
  • Table 28: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 29: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 30: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 31: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 35: China Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 36: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 37: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 38: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 39: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 40: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 41: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 43: India Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 44: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 45: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 46: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 47: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 49: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 50:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 51: Japan Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 52: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 53: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 54: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 55: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 56: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 57: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 58: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 59: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 60: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 61: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 62: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 63: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 65: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 66: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 67: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 69: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 70: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 71: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 72: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 73: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 74: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 75: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 77:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 78: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 79: Air Pollution And Air Quality Index in 2018, Western Europe Countries
  • Table 80: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 81: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 82: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 83: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 84: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 85: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 87: UK Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 88: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 89: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 90: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 91: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 92: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 93: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 94: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 95: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 96: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 97: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 98: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 99: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 100: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 101: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 102: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 103: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 104: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 105: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 106:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 107:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 108: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 109: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 110: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 111: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 112: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 113: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 114: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 115: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 116: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 117: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 118: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 119: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 120: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 121:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 122:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 123: North America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 124: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 125: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 126: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 127: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 128: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 129: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 130:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 131: USA Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 132: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 133: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 134: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 135: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 137: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 138:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 139:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 140: South America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 141: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 142: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 143: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 144: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 145: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 146: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 147: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 148: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 149: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 150: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 151: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 152: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 153:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 154:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 155: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 156: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 157: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 158: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 159: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 161: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 162:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 163:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 164: Africa Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 165: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Table 166: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 167: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 168: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 169: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 170: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 171: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 172: GlaxoSmithKline – Financial Performance, 2015 – 2019, $ Billion
  • Table 173: AstraZeneca plc. –  Financial Performance2015 – 2019, $ Billion
  • Table 174: Boehringer Ingelheim GmbH – Financial Performance, 2015  – 2019, $ Billion
  • Table 175: F. Hoffmann-La Roche Ltd. – Financial Performance, 2015 – 2019, $ Billion
  • Table 176: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 177: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Table 178: Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Table 179: Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 180: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Country
  • Table 181: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, Segmentation By Drug Class
  • Table 182: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Type Of End User
  • Table 183: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 – 2023, By Distribution Channel
  • Table 184: Anti-Asthmatics And COPD Drugs Market Data Sources

List Of Figures

    Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
  • Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
  • Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
  • Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
  • Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
  • Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
  • Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
  • Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
  • Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs
  • Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019
  • Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019
  • Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019
  • Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019
  • Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019
  • Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 99: GlaxoSmithKline – Financial Performance, 2015 – 2019, $ Billion
  • Figure 100: AstraZeneca plc. – Financial Performance2015 –  2019, $ Billion
  • Figure 101: Boehringer Ingelheim GmbH – Financial Performance, 2015 – 2019, $ Billion
  • Figure 102: F. Hoffmann-La Roche Ltd – Financial Performance, 2015 – 2019, $ Billion
  • Figure 103: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Figure 105: Global Respiratory Diseases Drugs Market, 2019, Split By Region
  • Figure 106: Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)